粪便挥发性有机化合物检测林奇综合征结直肠肿瘤:一项前瞻性纵向多中心研究
这项前瞻性纵向多中心研究纳入200例林奇综合征个体,在高质量监测结肠镜检查前后采集粪便,用FAIMS和GC-IMS分析VOC模式并结合FIT(2.55 μg Hb/g粪便)。FAIMS对CRC和AA的敏感性和NPV均为100%(特异性54%),GC-IMS为89%和99%(特异性58%);任何相关肿瘤的敏感性和特异性分别为FAIMS 88%和44%、GC-IMS 84%和28%,VOC-FIT未显著提高准确性。作者认为粪便VOC有望用于推迟结肠镜和息肉切除后随访,结果是大规模验证研究的垫脚石。
要点
- FAIMS对CRC和AA的敏感性和NPV均为100%,特异性54%。
- GC-IMS对CRC和AA的敏感性和NPV为89%和99%,特异性58%。
- 任何相关肿瘤准确性在联合FIT后未显著提高。
核心结论
- 在林奇综合征中,粪便VOC可能是推迟结肠镜和息肉切除后随访的有前景策略。
- 作者认为本研究结果是大规模验证研究的垫脚石。
研究设计与样本
- 前瞻性纵向多中心研究,林奇综合征个体在高品质监测结肠镜检查前后采集粪便。
- 共纳入200例个体(57%女性,中位年龄51岁),其中62例结肠镜检查时有相关肿瘤:3例CRC、6例AA、3例ASL、50例NAA。
- VOC模式用场不对称离子迁移谱(FAIMS)和气相色谱-离子迁移谱(GC-IMS)分析并结合机器学习流程,同时联合粪便免疫化学试验(FIT,2.55 μg Hb/g粪便)。
- 气相色谱-飞行时间质谱分析单个VOC丰度。
主要发现
- FAIMS对CRC和AA(以及ASL)的敏感性和阴性预测值均为100%,特异性54%。
- GC-IMS对CRC和AA的敏感性和阴性预测值分别为89%和99%,特异性58%。
- FAIMS对任何相关肿瘤的敏感性和特异性分别为88%和44%,GC-IMS分别为84%和28%。
- VOC联合FIT后准确性未显著提高。
- 息肉切除前后VOC模式不同(AUC 0.70)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 作者认为本研究结果是大规模验证研究的垫脚石。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Non-invasive biomarkers may reduce post-colonoscopy colorectal cancer (CRC) rates and colonoscopy overuse in Lynch syndrome. Unlike faecal immunochemical test (FIT), faecal volatile organic compounds (VOCs) may accurately detect both advanced and non-advanced colorectal neoplasia. AIM: The aim of this study was to evaluate the potential of faecal VOCs-separately and with FIT-to guide optimal colonoscopy intervals in Lynch syndrome. METHODS: Prospective longitudinal multicentre study in which individuals with Lynch syndrome collected faeces before and after high-quality surveillance colonoscopy. VOC-patterns were analysed using field asymmetric ion mobility spectrometry (FAIMS) and gas chromatography-ion mobility spectrometry (GC-IMS) followed by machine learning pipelines, and combined with FIT at 2.55 μg Hb/g faeces. Gas chromatography time-of-flight mass spectrometry analysed individual VOC abundance. RESULTS: Among 200 included individuals (57% female, median 51 years), 62 had relevant neoplasia at colonoscopy: 3 CRC, 6 advanced adenoma (AA), 3 advanced serrated lesion (ASL), and 50 non-advanced adenoma (NAA). Respective sensitivity and negative predictive value for CRC and AA (and also ASL in case of FAIMS) were 100% and 100% using FAIMS (54% specificity), and 89% and 99% using GC-IMS (58% specificity). Respective sensitivity and specificity for any relevant neoplasia were 88% and 44% (FAIMS) and 84% and 28% (GC-IMS); accuracy did not significantly improve upon VOC-FIT. VOC-patterns differed before and after polypectomy (AUC 0.70). NAA showed decreased faecal abundance of butanal, 2-oxohexane, dimethyldisulphide and dimethyltrisulphide. CONCLUSIONS: In Lynch syndrome, faecal VOCs may be a promising strategy for postponing colonoscopy and for follow-up after polypectomy. Our results serve as a stepping stone for large validation studies. TRIAL REGISTRATION: NL8749.
引用
- van Liere ELSA, Ramsoekh D, Daulton E, et al. Faecal Volatile Organic Compounds to Detect Colorectal Neoplasia in Lynch Syndrome-A Prospective Longitudinal Multicentre Study. Aliment Pharmacol Ther. 2024. PMID: 39422092. doi:10.1111/apt.18328
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。